5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.60▼ | 8.61▼ | 8.56▼ | 8.18▲ | 7.40▲ |
MA10 | 8.59▼ | 8.54▼ | 8.45▲ | 7.95▲ | 7.45▲ |
MA20 | 8.63▼ | 8.43▲ | 8.37▲ | 7.39▲ | 7.70▲ |
MA50 | 8.55▼ | 8.28▲ | 8.10▲ | 7.37▲ | 8.15▲ |
MA100 | 8.44▲ | 8.08▲ | 7.70▲ | 7.82▲ | 6.60▲ |
MA200 | 8.36▲ | 7.60▲ | 7.36▲ | 8.52▲ | 6.22▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.014▼ | 0.013▲ | 0.014▲ | 0.138▲ | 0.062▲ |
RSI | 41.723▼ | 59.407▲ | 64.370▲ | 63.142▲ | 55.362▲ |
STOCH | 41.465 | 84.585▲ | 90.333▲ | 83.823▲ | 52.552 |
WILL %R | -100.000▼ | -26.230 | -26.230 | -6.828▲ | -12.440▲ |
CCI | -144.648▼ | 64.250 | 105.902▲ | 126.404▲ | 147.127▲ |
Tuesday, April 29, 2025 05:00 AM
BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced ...
|
Monday, April 28, 2025 05:00 AM
BEDFORD, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (OCUL) (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining ...
|
Thursday, April 17, 2025 04:11 AM
On Monday, BofA Securities adjusted its outlook on Ocular Therapeutix (NASDAQ:OCUL), reducing the price target to $17 from the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 8.28 | 8.70 | 8.07 | 8.53 | 1,484,232 |
30/04/25 | 8.20 | 8.395 | 8.12 | 8.30 | 1,002,571 |
29/04/25 | 8.14 | 8.41 | 8.04 | 8.21 | 853,657 |
28/04/25 | 7.76 | 8.19 | 7.74 | 8.13 | 963,853 |
25/04/25 | 7.79 | 7.955 | 7.62 | 7.71 | 1,705,534 |
24/04/25 | 7.84 | 7.98 | 7.75 | 7.90 | 2,042,290 |
23/04/25 | 8.14 | 8.23 | 7.83 | 7.85 | 957,768 |
22/04/25 | 7.71 | 8.07 | 7.62 | 7.91 | 1,022,792 |
21/04/25 | 7.19 | 7.80 | 7.12 | 7.61 | 975,863 |
17/04/25 | 7.16 | 7.38 | 7.12 | 7.31 | 1,633,181 |
|
|
||||
|
|
||||
|
|